PPP3CB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.450820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.737000E-01
Normal-vs-Stage2
2.735600E-02
Normal-vs-Stage3
3.237800E-02
Normal-vs-Stage4
3.322800E-01
Stage1-vs-Stage2
1.117600E-01
Stage1-vs-Stage3
1.088000E-01
Stage1-vs-Stage4
7.030200E-01
Stage2-vs-Stage3
1.950160E-01
Stage2-vs-Stage4
5.035400E-01
Stage3-vs-Stage4
2.587200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.667030E-01
Normal-vs-AfricanAmerican
1.459370E-01
Normal-vs-Asian
2.038000E-02
Caucasian-vs-AfricanAmerican
7.234200E-01
Caucasian-vs-Asian
2.385000E-01
AfricanAmerican-vs-Asian
1.402230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.342580E-01
Normal-vs-Female
1.760370E-01
Male-vs-Female
5.097400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.967800E-02
Normal-vs-Age(41-60Yrs)
3.041200E-01
Normal-vs-Age(61-80Yrs)
1.222850E-01
Normal-vs-Age(81-100Yrs)
8.001000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.491600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.078800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.213000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.911700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.461900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.583400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.116190E-02
Normal-vs-Daily Drinker
1.751920E-02
Normal-vs-Weekly Drinker
2.184400E-02
Normal-vs-Occasional Drinker
7.442600E-01
Normal-vs-Social Drinker
3.843200E-01
Non Drinker-vs-Daily Drinker
8.219600E-01
Non Drinker-vs-Weekly Drinker
4.824000E-01
Non Drinker-vs-Occasional Drinker
9.673900E-02
Non Drinker-vs-Social Drinker
4.127800E-02
Daily Drinker-vs-Weekly Drinker
6.323200E-01
Daily Drinker-vs-Occasional Drinker
1.200230E-01
Daily Drinker-vs-Social Drinker
8.300400E-02
Weekly Drinker-vs-Occasional Drinker
1.863020E-01
Weekly Drinker-vs-Social Drinker
2.148600E-01
Occasional Drinker-vs-Social Drinker
6.708000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.211200E-01
Normal-vs-Grade 2
6.610500E-02
Normal-vs-Grade 3
6.455900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.624950E-01
Grade 1-vs-Grade 3
9.057700E-02
Grade 1-vs-Grade 4
2.211200E-01
Grade 2-vs-Grade 3
4.364200E-01
Grade 2-vs-Grade 4
6.610500E-02
Grade 3-vs-Grade 4
6.455900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.560570E-01
Normal-vs-NonDiabetic
1.123250E-01
Diabetic-vs-NonDiabetic
7.103200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.065720E-02
Normal-vs-NoPancreatitis
1.597980E-01
Pancreatitis-vs-NoPancreatitis
1.954810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.712000E-01
Normal-vs-N1
3.002300E-02
N0-vs-N1
1.068620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.884760E-03
Normal-vs-TP53-NonMutant
5.342800E-01
TP53-Mutant-vs-TP53-NonMutant
2.010700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
